Munehiro Kitada

13PUBLICATIONS
9CO-AUTHORS
Molecular targetsExercise physiologySpeciation and extinctionCancer cell biologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 02, 2022
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.

Satoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw

|Jan 31, 2022
Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice.

Keiji Shimada, Keizo Kanasaki, Makoto Kato

|Jan 11, 2022
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches.

Jing Xu, Taro Hirai, Daisuke Koya

|Nov 27, 2021
Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats.

Itaru Monno, Yoshio Ogura, Jing Xu

|Sep 11, 2021
Autophagy in metabolic disease and ageing.

Munehiro Kitada, Daisuke Koya

|Aug 27, 2021
Sirtuins and Renal Oxidative Stress.

Yoshio Ogura, Munehiro Kitada, Daisuke Koya

Pageof 3

Frequent Collaborators

11 joint publications

Daisuke Koya

4 joint publications

Taro Hirai

3 joint publications

Keizo Kanasaki

1 joint publications

Yuiko Mizunuma